Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001618835-21-000271
Filing Date
2021-12-20
Accepted
2021-12-20 16:19:18
Documents
1
Period of Report
2021-12-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164003514607858.html 4  
1 FORM 4 wf-form4_164003514607858.xml 4 3097
  Complete submission text file 0001618835-21-000271.txt   4618
Mailing Address C/O EVOFEM BIOSCIENCES, INC. 12400 HIGH BLUFF DRIVE, SUITE 600 SAN DIEGO CA 92130
Business Address
PELLETIER SAUNDRA L (Reporting) CIK: 0001251371 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36754 | Film No.: 211505505

Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Issuer) CIK: 0001618835 (see all company filings)

EIN.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations